HTX-011 Approval Status
FDA Approved: No
Brand name: HTX-011
Generic name: bupivacaine and meloxicam
Company: Heron Therapeutics, Inc.
Treatment for: Postoperative Pain
HTX-011 (bupivacaine and meloxicam) is an investigational fixed-dose combination of the local anesthetic bupivacaine and the nonsteroidal anti-inflammatory drug (NSAID) meloxicam in development for the management of postoperative pain.
Development Status and FDA Approval Process for HTX-011
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.